Arkolith/Insider Trading/IKNA/Form 4

Zhang Xiaoyan Michelle

Chief Scientific OfficerIkena Oncology, Inc. (IKNA) · full profile →Form 4 · filed Dec 14, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15K
Net Open-Market Flow
-$15K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 10, 2021Sell(S)1K$14.76$15K44K
Dec 10, 2021Option exercise(M)1K$2.15$2K45K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 10, 2021Option exercise(M)1K—$025K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-048230) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML